Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1995 1
1996 4
1997 2
1998 2
1999 1
2000 2
2001 1
2002 3
2003 3
2004 1
2005 2
2006 2
2007 3
2008 1
2010 4
2011 9
2012 8
2013 9
2014 7
2015 20
2016 14
2017 6
2018 11
2019 17
2020 12
2021 28
2022 14
2023 17
2024 21
2025 10
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group. El Sahly HM, et al. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551225 Free PMC article. Clinical Trial.
Syphilis.
Eickhoff CA, Decker CF. Eickhoff CA, et al. Dis Mon. 2016 Aug;62(8):280-6. doi: 10.1016/j.disamonth.2016.03.012. Epub 2016 Apr 15. Dis Mon. 2016. PMID: 27091635 Review. No abstract available.
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension.
Singh N, Eickhoff C, Garcia-Agundez A, Bertone P, Paudel SS, Tambe DT, Litzky LA, Cox-Flaherty K, Klinger JR, Monaghan SF, Mullin CJ, Pereira M, Walsh T, Whittenhall M, Stevens T, Harrington EO, Ventetuolo CE. Singh N, et al. Among authors: eickhoff c. Sci Rep. 2023 Dec 18;13(1):22534. doi: 10.1038/s41598-023-48077-6. Sci Rep. 2023. PMID: 38110438 Free PMC article.
Th9 cells provide protective TB immunity.
Xia M, Blazevic A, Ning H, Eickhoff CS, Storer CE, Head RD, Liu J, Jarvela J, Stoeckel D, Rakey E, Tennant J, Miller DL, Holloway KR, Silver RF, Hoft DF. Xia M, et al. Among authors: eickhoff cs. Front Immunol. 2025 Oct 6;16:1581286. doi: 10.3389/fimmu.2025.1581286. eCollection 2025. Front Immunol. 2025. PMID: 41122175 Free PMC article.
Advancing health equity with artificial intelligence.
Thomasian NM, Eickhoff C, Adashi EY. Thomasian NM, et al. Among authors: eickhoff c. J Public Health Policy. 2021 Dec;42(4):602-611. doi: 10.1057/s41271-021-00319-5. Epub 2021 Nov 22. J Public Health Policy. 2021. PMID: 34811466 Free PMC article. Review.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
216 results